Timing of treatment initiation in Parkinson's disease: a need for reappraisal?
Schapira
Anthony H V
AH
University Department of Clinical Neurosciences, Royal Free and University College Medical School, University College London, UK. a.schapira@medsch.ucl.ac.uk
Obeso
Jose
J
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D006301:Health Services Needs and Demand; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D013997:Time Factors
D000978:Antiparkinson Agents